Application Health and Innovation Thought Leader Delegation till Singapore, 19-21 November 2024
| Reference number | |
| Coordinator | NEOGAP Therapeutics AB |
| Funding from Vinnova | SEK 24 549 |
| Project duration | November 2024 - November 2024 |
| Status | Completed |
| Venture | Global cooperation 2024 |
Important results from the project
Vi satte inga mål och ansökningstuden var formidabelt kort
Expected long term effects
It is to early to speculate about the far-reaching effects. It is clear that the product has an enormous potential to become the dominant player in the field of solid cancer.
Approach and implementation
We carried out the project, the trip to Singapore and took the opportunity to establish an interesting collaboration